Breaking News Instant updates and real-time market news.

IBM

IBM

$153.01

-1.23 (-0.80%)

07:01
07/18/17
07/18
07:01
07/18/17
07:01

Technical Earnings Preview: IBM has a potential bearish pattern

The stock has been in a consolidation phase for the last three months following a sharp decline in price. On a long-term monthly basis the price action from July of last year to present resembles an irregular bearish head and shoulders /bearish cup and handle pattern. A drop below $150 on negative news would see the pattern become active. Downside potential would be to the $120 area if the pattern became active and completed. Initial support would be at the 52-week low at $147.79, $142.36, and the $140 area. If the news is a positive surprise, a breakout above the right shoulder of the pattern at $157.50 or higher would void it. Next resistance levels to watch in that event as potential upside objectives would be at $158.85, $160, and $165.99.

IBM IBM
$153.01

-1.23 (-0.80%)

07/17/17
LEHM
07/17/17
NO CHANGE
Target $132
LEHM
Underweight
Barclays calls on IBM to cut outlook, drops price target to $132
IBM should take the "brave step" and drastically reset its full-year earnings per share outlook to $13.00 or lower, Barclays analyst Mark Moskowitz tells investors in a research note. He believes the company's narrative is "becoming tedious" with a lot of investments in next-generation technology generating little revenue impact. The analyst cut his below-consensus estimates for 2017 and 2018 and dropped his price target for IBM shares to $132 from $141. The technology company closed Friday up 61c to $154.24. Moskowitz keeps an Underweight rating on the shares. He views IBM's valuation as "stretched" and does not think cost cuts will be enough to counter increasing exposure to cloud-related or "as-a-service" revenue that carries lower revenue and profit.
07/12/17
JEFF
07/12/17
NO CHANGE
Target $125
JEFF
Underperform
IBM price target lowered to $125 from $135 at Jefferies
Jefferies analyst James Kisner lowered his price target for IBM (IBM) to $125 and reiterates an Underperform rating on the shares. While channel checks indicate IBM's Watson platform remains one of the most complete cognitive platforms available in the marketplace today, the "hefty services" component of many artificial intelligence deployments will be a hindrance to adoption, Kisner tells investors in a research note titled "Creating Shareholder Value with AI? Not so Elementary, My Dear Watson." The analyst also believes IBM looks "outgunned in the war" for AI talent and will likely see increasing competition. Kisner adds that his firm believes Nvidia (NVDA) is the biggest beneficiary of ramping AI adoption. He lists Pure Storage (PSTG) and Mellanox (MLNX) as other beneficiaries.
07/10/17
KEYB
07/10/17
NO CHANGE
KEYB
IT services companies can benefit from AI opportunity, says KeyBanc
KeyBanc analyst Arvind Ramnani says that IT services companies such as Cognizant (CTSH), Accenture (ACN) and IBM (IBM) can benefit significantly as enterprises look to access data in order to enable artificial intelligence. The analyst adds that Talend's (TLND) data integration tools can also benefit from this trend. He keeps Overweight ratings on all the stocks named, except that he keeps a Sector Weight rating on IBM.
06/22/17
CLVD
06/22/17
INITIATION
CLVD
Neutral
IBM initiated with a Neutral at Cleveland Research
Cleveland Research initiated IBM with a Neutral with a $154 price target saying channel sentiment has improved over the last six months driven by better installed base retention and wallet share gains from cloud and software as a service offerings. The analyst is slightly ahead of consensus for earnings through FY19 and said there could be some upside to revenue assumptions should Services stabilize adn partner growth outlooks materialize.

TODAY'S FREE FLY STORIES

TERP

TerraForm Power

$13.58

0.62 (4.78%)

05:06
10/19/17
10/19
05:06
10/19/17
05:06
Initiation
TerraForm Power initiated  »

TerraForm Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$55.77

0.71 (1.29%)

05:04
10/19/17
10/19
05:04
10/19/17
05:04
Recommendations
Abbott analyst commentary  »

Abbott price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$187.15

-10.63 (-5.37%)

05:00
10/19/17
10/19
05:00
10/19/17
05:00
Recommendations
Allergan analyst commentary  »

Allergan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

MERC

Mercer

$13.50

-0.05 (-0.37%)

04:58
10/19/17
10/19
04:58
10/19/17
04:58
Upgrade
Mercer rating change  »

Mercer upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ADBE

Adobe

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

ANGI

Angie's List

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Upgrade
Angie's List rating change  »

Angie's List…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

GWW

Grainger

$208.81

3.39 (1.65%)

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Downgrade
Grainger rating change  »

Grainger downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

MZOR

Mazor Robotics

$58.55

3.57 (6.49%)

, NUVA

NuVasive

$54.18

0.47 (0.88%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Downgrade
Mazor Robotics, NuVasive rating change  »

Mazor Robotics downgraded…

MZOR

Mazor Robotics

$58.55

3.57 (6.49%)

NUVA

NuVasive

$54.18

0.47 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/13 EIA Natural…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/18 Fed Balance…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/9 Money Supply…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

MTCH

Match Group

$25.52

-0.56 (-2.15%)

, IAC

IAC

$124.60

-0.55 (-0.44%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Jefferies Internet analysts hold an analyst/industry conference call »

Internet Analysts…

MTCH

Match Group

$25.52

-0.56 (-2.15%)

IAC

IAC

$124.60

-0.55 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 08

    Nov

  • 09

    Nov

UBS

UBS

$17.26

0.02 (0.12%)

, CME

CME Group

$136.37

0.18 (0.13%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Futures Industry Association to hold an expo »

33rd Annual FIA Futures…

UBS

UBS

$17.26

0.02 (0.12%)

CME

CME Group

$136.37

0.18 (0.13%)

NDAQ

Nasdaq

$74.60

-0.11 (-0.15%)

ICE

IntercontinentalExchange

$68.20

0.03 (0.04%)

CBOE

CBOE Holdings

$109.59

0.06 (0.05%)

BAC

Bank of America

$26.48

0.28 (1.07%)

GS

Goldman Sachs

$242.03

5.94 (2.52%)

JPM

JPMorgan

$97.99

0.37 (0.38%)

CS

Credit Suisse

$15.91

-0.11 (-0.69%)

C

Citi

$73.12

0.93 (1.29%)

AMZN

Amazon.com

$997.00

-12.13 (-1.20%)

MS

Morgan Stanley

$50.15

1.03 (2.10%)

WFC

Wells Fargo

$53.41

0.22 (0.41%)

AMTD

TD Ameritrade

$47.54

0.32 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 02

    Nov

  • 02

    Nov

  • 05

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 20

    Nov

  • 29

    Nov

  • 15

    Jan

  • 27

    Feb

  • 18

    Mar

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

VPG

Vishay Precision

$24.40

0.55 (2.31%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Vishay Precision management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 07

    Nov

SCS

Steelcase

$15.30

0.1 (0.66%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Steelcase management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 25

    Oct

  • 26

    Oct

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Philadelphia Fed Business Outlook Survey General Conditions Index to be reported at 08:30 »

October Philadelphia Fed…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Kansas City Federal…

SB

Safe Bulkers

$3.12

-0.01 (-0.32%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Safe Bulkers management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

SNY

Sanofi

$49.53

-0.06 (-0.12%)

, PFE

Pfizer

$35.83

-0.37 (-1.02%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Drug Information Association to hold a conference »

Metrics in…

SNY

Sanofi

$49.53

-0.06 (-0.12%)

PFE

Pfizer

$35.83

-0.37 (-1.02%)

ALKS

Alkermes

$51.09

-0.39 (-0.76%)

LLY

Eli Lilly

$85.73

-0.33 (-0.38%)

BMY

Bristol-Myers

$63.70

-0.48 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 20

    Oct

  • 20

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 31

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

COST

Costco

$157.55

-0.83 (-0.52%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Costco management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/15 Bloomberg…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Leading Indicators to be reported at 10:00 »

September Leading…

PLX

Protalix

$0.83

0.176 (26.91%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Protalix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

GNCA

Genocea

$1.43

-0.12 (-7.74%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Genocea management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.